Literature DB >> 11337702

Methodology of biofeedback for adults with fecal incontinence: a program of care.

C Norton1, S Chelvanayagam.   

Abstract

In a previous article we described a nursing assessment for adults with fecal incontinence. This article outlines in detail the program of care, tailored to an individual's assessed needs, that is available in the nurse-led biofeedback service for fecal incontinence at St Mark's Hospital in England. A recent evaluation of this program found that two thirds of patients reported improved fecal continence after receiving care from this service.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11337702     DOI： 10.1067/mjw.2001.114897

Source DB:  PubMed          Journal:  J Wound Ostomy Continence Nurs        ISSN： 1071-5754            Impact factor:   1.741


  4 in total

1.  Biofeedback therapy for symptoms of bowel dysfunction following surgery for colorectal cancer.

Authors:  L Bartlett; K Sloots; M Nowak; Y-H Ho
Journal:  Tech Coloproctol       Date:  2011-07-14       Impact factor: 3.781

Review 2.  Pelvic floor rehabilitation in the treatment of fecal incontinence.

Authors:  Kelly M Scott
Journal:  Clin Colon Rectal Surg       Date:  2014-09

3.  Bowel symptoms and self-care strategies of survivors in the process of restoration after low anterior resection of rectal cancer.

Authors:  Lishi Yin; Ling Fan; Renfu Tan; Guangjing Yang; Fenglin Jiang; Chao Zhang; Jun Ma; Yang Yan; Yanhong Zou; Yaowen Zhang; Yamei Wang; Guifang Zhang
Journal:  BMC Surg       Date:  2018-06-04       Impact factor: 2.102

4.  Supported online self-management versus care as usual for symptoms of fatigue, pain and urgency/incontinence in adults with inflammatory bowel disease (IBD-BOOST): study protocol for a randomised controlled trial.

Authors:  Christine Norton; Jonathan Syred; Sally Kerry; Micol Artom; Louise Sweeney; Ailsa Hart; Wladyslawa Czuber-Dochan; Stephanie J C Taylor; Borislava Mihaylova; Chris Roukas; Qasim Aziz; Laura Miller; Richard Pollok; Sonia Saxena; Imogen Stagg; Helen Terry; Zohra Zenasni; Lesley Dibley; Rona Moss-Morris
Journal:  Trials       Date:  2021-08-03       Impact factor: 2.279
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.